In this regard, we found that, Chk2 deletion lead to a slightly increased tumor incidence compared to the single Terc-deficient cohorts (Fig. 3G), suggesting that Chk2 could partially abolish the tumor suppressor effect of Terc deficiency. The gene discussed is CHEK2; the disease is neoplasm.